Comparison of vaginal Bon Sorkh with clotrimazole on treatment of vulvovaginal candidiasis

Comparison of Bon Sorkh vaginal gel with vaginal cream of clotrimazole on treatment of vulvovaginal candidiasis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161031030595N2

Enrollment

100

Registered

2018-03-17

Start date

2018-04-14

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vulvovaginal Candidiasis. Candidiasis of vulva and vagina

Interventions

Intervention 1: In the control group, clotrimazole vaginal cream. Intervention 2: In the intervention group, vaginal gel bonsorkh.

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: They were not at pregnancy. They had not used antibiotics, immunosuppressive drugs, or vaginal drugs 14 days before the study

Exclusion criteria

Exclusion criteria: They had not previously suffered from known medical diseases such as diabetes, immune system attenuating diseases (such as AIDS) or auto-immune diseases, coagulation disorders, and epilepsy.

Design outcomes

Primary

Measure	Time frame
Vaginal discharge. Timepoint: Initially, four and eight days after treatment. Method of measurement: Self-administered questionnaire.	—

Secondary

Measure	Time frame
Pruritus. Timepoint: Initially, four and eight days after treatment. Method of measurement: Self-administered questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHeibatullah kalantari

School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences

kalantari-h@ajums.ac.ir+98 986133738378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026